CompletedNCT00550407
This study is completed. It focuses on bipolarity and currently lists study information in Japan.
BipolarityOtherOver 20 Years
- Countries
- Japan
- Sponsor
- GlaxoSmithKline
- Condition
- Bipolarity
WithdrawnNCT00221481
This study has public registry information. It focuses on bipolarity and currently lists study information in the United States.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Mayo Clinic
- Condition
- Bipolarity
CompletedNCT01852357
This study is completed. It focuses on ADHD and currently lists study information in the United States.
ADHDOtherFrom 18 Years to 40 Years
- Countries
- United States
- Sponsor
- University of North Carolina, Wilmington
- Condition
- ADHD
TerminatedNCT05741502
This study has public registry information. It focuses on schizophrenia and currently lists study information in the United States.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Ohio State University
- Condition
- Schizophrenia
CompletedNCT06486948
This study is completed in the United States. It focuses on schizophrenia.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Click Therapeutics, Inc.
- Condition
- Schizophrenia
TerminatedNCT03065933
This study has public registry information in Global. It focuses on Bipolarity.
BipolarityOtherFrom 18 Years to 60 Years
- Countries
- Global
- Sponsor
- Mclean Hospital
- Condition
- Bipolarity
TerminatedNCT05526833
This study has public registry information. It focuses on schizophrenia and currently lists study information in the United States.
SchizophreniaOtherFrom 22 Years to 55 Years
- Countries
- United States
- Sponsor
- Columbia University
- Condition
- Schizophrenia
CompletedNCT06067984
This study is completed in the United States. It is testing a Second Course of a Digital Therapeutic for schizophrenia.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Click Therapeutics, Inc.
- Condition
- Schizophrenia
CompletedNCT02970929
This study is completed. It focuses on schizophrenia and currently lists study information in Hungary, Romania, Russian Federation, Ukraine, and the United States.
SchizophreniaOtherFrom 18 Years to 40 Years
- Countries
- United States, Hungary, Romania, ...
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
CompletedNCT05741528
This study is completed in the United States. It focuses on schizophrenia.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
CompletedNCT04659174
This study is completed in the United States and in Ukraine. It is testing Long-term Safety, Tolerability, and Efficacy of KarXT for schizophrenia.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States, Ukraine
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Condition
- Schizophrenia
TerminatedNCT02259517
This study has public registry information. It focuses on ADHD and currently lists study information in the United States.
ADHDOtherFrom 6 Years to 17 Years
- Countries
- United States
- Sponsor
- New York State Psychiatric Institute
- Condition
- ADHD
